
Kinarus Therapeutics Holding AG
SIX:KNRS

Fundamental Analysis


Revenue & Expenses Breakdown
Kinarus Therapeutics Holding AG
Balance Sheet Decomposition
Kinarus Therapeutics Holding AG
Current Assets | 111k |
Receivables | 108k |
Other Current Assets | 3k |
Free Cash Flow Analysis
Kinarus Therapeutics Holding AG
CHF | |
Free Cash Flow | CHF |
Earnings Waterfall
Kinarus Therapeutics Holding AG
Revenue
|
0
CHF
|
Operating Expenses
|
-13.9m
CHF
|
Operating Income
|
-13.9m
CHF
|
Other Expenses
|
-6k
CHF
|
Net Income
|
-13.9m
CHF
|
KNRS Profitability Score
Profitability Due Diligence
Kinarus Therapeutics Holding AG's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Score
Kinarus Therapeutics Holding AG's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
KNRS Solvency Score
Solvency Due Diligence
Kinarus Therapeutics Holding AG's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Score
Kinarus Therapeutics Holding AG's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KNRS Price Targets Summary
Kinarus Therapeutics Holding AG
Dividends
Current shareholder yield for KNRS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?